Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
Latest news on ALLERGAN, INC.
06/07 Mylan defends chairman to ISS ahead of June 22 investor vote
06/07 ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
06/05 FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
06/02 U.S. state, local government lawsuits over opioids face uphill battle
05/31 ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
05/26 ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
05/25 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/24 ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
05/23 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/16 ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance..
05/16 ALLERGAN : VIBERZI™ Now Approved in Canada for patients with irritable bow..
05/16 Several top fund managers trim Allergan stakes in first quarter
05/16 CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quart..
05/13 High-profile Snap stakeholders revealed in filings
05/13 High-profile Snap stakeholders revealed in filings
05/11 ALLERGAN, INC. : Today's Research Reports on Stocks to Watch: Allergan and Celge..
05/10 ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
05/09 Allergan posts loss as it writes down Teva holdings
05/09 Allergan posts loss as it writes down Teva holdings
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09 ALLERGAN PLC (NYSE : AGN) reported earnings of $3.35 per share beating Walls Str..
05/09 ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
05/09 ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
05/09 ALLERGAN : tops Street 1Q forecasts, deal fuels guidance hike
05/05 ALLERGAN PLC (NYSE : AGN) Files An 8-K Submission of Matters to a Vote of Securi..
05/05 ALLERGAN PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
05/04 ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and..
04/29 ALLERGAN : Successfully Completes ZELTIQ Aesthetics Acquisition
04/27 NOVARTIS : Allergan Expands Leading Research & Development NASH Program with Nov..
04/26 ALLERGAN : Granted Marketing Authorization by the FDA for TrueTear, the First In..
04/19 ALLERGAN : Novartis expands development programs for NASH through clinical colla..
04/18 ALLERGAN PLC (NYSE : AGN) Files An 8-K Other Events
04/18 ALLERGAN PLC : Other Events (form 8-K)
04/14 ALLERGAN : Exclusive New Interview Released with Allergan Global Regulatory Affa..
04/13 ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
04/12 ALLERGAN : New Interview Released with Allergan Global Regulatory Affairs Direct..
04/12 ALLERGAN PLC ORDINARY SHARES’ : AGN) Initiative Creating Awareness to Peo..
04/12 ALLERGAN : Introducing Juvederm Vollure® at The Choe Center
04/12 Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
04/11 ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
04/08 ALLERGAN : After iffy phase 2, Allergan plows forward with phase 3 Botox depress..
04/07 ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
04/07 ALLERGAN : acquires Zeltiq
04/07 ALLERGAN : To Test Botox For Depression Despite Mixed Results
04/06 IMPAX LABORATORIES : Board of Directors Appoints Paul M. Bisaro President and CE..
04/05 ALLERGAN : Center for Facial Rejuvenation's Cindy Wilson, NP Chosen as Official ..
04/05 ALLERGAN : exec Sanjiv Patel becomes new CEO at upstart Relay
04/02 ALLERGAN : Dr. Rubinstein Receives Allergan "Top 500" Award
03/30 ALLERGAN : FDA Approves Juvéderm Vollure XC for Laugh Lines, Notes Dr. F. Victor..
03/29 ALLERGAN : Dr. Justin Harper Selected for Allergans Facial Aesthetics National A..
03/29 ALLERGAN : Paratek hit late-stage acne goals, prep for sarecycline NDA
03/28 ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
03/28 ALLERGAN : Paratek Announce Positive Results from Two Phase 3 Trials for Moderat..
03/28 ALLERGAN : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National ..
03/27 ALLERGAN : and Paratek Show Positive Results For Acne Treatment
03/27 PARATEK PHARMACEUTICALS, INC. (NASDA : PRTK) Files An 8-K Regulation FD Disclosu..
03/27 ALLERGAN : What Are Inversion Deals?
03/24 GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
03/24 GLOBAL GASTROINTESTINAL DRUGS MARKET : Abbott Laboratories, Allergan, AstraZenec..
03/22 Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
03/22 ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
03/20 ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
03/17 ALLERGAN : Prevent Blindness and Allergan Work Together Through See America to P..
03/17 ALLERGAN : Editas partner on CRISPR tech in eye diseases
03/17 ALLERGAN : Lupin in fast lane with 5 launches in 15 days
03/16 ALLERGAN : Prevent Blindness and Allergan Work Together Through 'See America' to..
03/16 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella for Lip Fullness And ..
03/16 ALLERGAN : celebrates commitment to KSA with new entity inaugural
03/15 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella® for Lip Fullness And..
03/15 EDITAS MEDICINE,INC. (NASDAQ : EDIT) Files An 8-K Entry into a Material Definiti..
03/15 Heptares adds Daiichi pain pact to string of R&D deals
03/15 ALLERGAN : Blindness treatment key to deal
03/14 ALLERGAN : Common explains why he's fighting against a blindness epidemic most p..
1  2  3  4  5  6  7  8  9  10Next
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.15%218 773
PFIZER9.30%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659